Person profile
Public information reviewedIvan Tornos
Board role
Chair · Zimmer Biomet (NYSE: ZBH)
Zimmer Biomet (NYSE: ZBH)
Chair · Current mandate
- Public sources
- 5 reviewed
- Profile ownership
- Not yet claimed
- Last reviewed
- May 16, 2026
Person profile
Public information reviewedBoard role
Chair · Zimmer Biomet (NYSE: ZBH)
Zimmer Biomet (NYSE: ZBH)
Chair · Current mandate
Identity, professional record and current appointments.
Overview
A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.
Professional narrative
Chairman, President and CEO of Zimmer Biomet since August 2023. Extensive experience in medical device industry with prior roles at BD and Bard. Expertise in financial management, strategic planning, mergers and acquisitions, business integration, risk management and regulatory aspects of highly regulated global enterprises.
Sources are shown with the information they support.
Current roles
Jan 1, 2023 – Present
Independence: Not independent
Source effective: 2026-04-01 · Observed: 2026-05-03T01:17:02.098+00:00
Board appointments, committee responsibilities and disclosed relationships.
Board and advisory record
Sources are shown with each role, education record, or credential.
Explore the roles, education and affiliations published in this record.
2023-01-01 → End not stated
current · source reported
Observed: 2026-09-21
Dashed lines mark past roles. Select a connection to see its dates and sources.
Relationship map
Direct relationships from verified facts and published résumé records. Private connections are excluded.
Direct public links only
Only published affiliations are shown here. Private relationships require authorized access.
Career history, education, credentials and public contributions.
Published record
Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.
Identifiers, sources, dates and record limitations.
Sources
Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.
SEC EDGAR
Sec Filing · Tier 3 · Reviewed May 3, 2026
SEC EDGAR
Sec Filing · Tier 3 · Reviewed May 3, 2026
Public Source · Tier not stated · Reviewed Not stated
Sec Filing · Tier 3 · Reviewed May 16, 2026
Sec Filing · Tier 3 · Reviewed May 16, 2026
SEC EDGAR
Sec Filing · Tier 3 · Reviewed May 3, 2026
Sec Filing · Tier 3 · Reviewed May 14, 2026
Sec Filing · Tier 3 · Reviewed May 16, 2026
Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background
Sec Proxy · Tier not stated · Reviewed May 3, 2026
Supports: Chair at Zimmer Biomet (NYSE: ZBH)
Sec Filing · Tier 3 · Reviewed May 14, 2026
Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Other Company Role · Technology background
SEC EDGAR
Sec Filing · Tier 3 · Reviewed May 3, 2026
Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title
Public Source · Tier not stated · Reviewed Not stated
Supports: Board membership